Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters

AIM: To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC). METHODS: An immunohistochemical study of E-cadherin and P120 catenin was performed on 42 specimens of ICC with a Dako Envision kit. RESULTS: The expressi...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 14; no. 23; pp. 3739 - 3744
Main Authors Zhai, Bo, Yan, He-Xin, Liu, Shu-Qin, Chen, Lei, Wu, Meng-Chao, Wang, Hong-Yang
Format Journal Article
LanguageEnglish
Published United States Department of Ultrasonic Intervention, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China%International Cooperation Laboratory on Signal Transduction, Eastern Hepatobilliary Surgery Institute, Second Military Medical University, Shanghai 200438, China 21.06.2008
The WJG Press and Baishideng
Subjects
Online AccessGet full text
ISSN1007-9327
2219-2840
DOI10.3748/wjg.14.3739

Cover

Abstract AIM: To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC). METHODS: An immunohistochemical study of E-cadherin and P120 catenin was performed on 42 specimens of ICC with a Dako Envision kit. RESULTS: The expression of E-cadherin and P120 was reduced in 27 cases (64.3%) and 31 cases (73.8%), respectively. Both E-cadherin and P120 expressions were significantly correlated with the tumor histological grade (χ^2 = 9.333, P = 009 and χ^= 11.71, P = 0.003), TNM stage (χ^= 8.627, P = 0.035 and χ^= 13.123, P = 0.004), intrahepatic metastasis (χ^= 7.292, P = 0.007 and χ^= 4.657, P = 0.041, respectively) and patients′ survival (χ^= 6.351, P = 0.002 and χ^= 4.023, P = 0.000, respectively). In addition, the expression of P120 was in concordance with that of E-cadherin (χ^ = 13.797, P = 0.000), indicating that the expression of P120 may be dependent on that of E-cadherin. Finally, only P120 expression was found to be an independent prognostic factor in Cox regression model (r = 0.088, P = 0.049). CONCLUSION: Down-regulated expression of E-cadherin and P120 occurs frequently in ICC and contributes to the progression and development of tumor. Both of them may be valuable biologic markers for predicting tumor invasion, metastasis and patients′ survival, but only P120 is an independent prognostic factor for ICC.
AbstractList R73; AIM: To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC).METHODS: An immunohistochemical study of E-cadherin and P120 catenin was performed on 42 specimens of ICC with a Dako Envision kit.RESULTS: The expression of E-cadherin and P120 was reduced in 27 cases (64.3%) and 31 cases (73.8%), respectively. Both E-cadherin and P120 expressions were significantly correlated with the tumor histological grade (X2=9.333, P=009 and X2=11.71, P=0.003), TNM stage (X2=8.627, P=0.035 and X2=13.123, P=0.004), intrahepatic metastasis (X2=7.292, P=0.007 and X2=4.657, P=0.041, respectively) and patients' survival (X2=6.351, P=0.002 and X2=4.023, P=0.000, respectively). In addition, the expression of P120 was in concordance with that of E-cadherin (X2=13.797, P=0.000), indicating that the expression of P120 may be dependent on that of E-cadherin. Finally, only P120 expression was found to be an independent prognostic factor in Cox regression model (r=0.088, P=0.049).CONCLUSION: Down-regulated expression of E-cadherin and P120 occurs frequently in ICC and contributes to the progression and development of tumor. Both of them may be valuable biologic markers for predicting tumor invasion, metastasis and patients' survival, but only P120 is an independent prognostic factor for ICC.
AIM: To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC). METHODS: An immunohistochemical study of E-cadherin and P120 catenin was performed on 42 specimens of ICC with a Dako Envision kit. RESULTS: The expression of E-cadherin and P120 was reduced in 27 cases (64.3%) and 31 cases (73.8%), respectively. Both E-cadherin and P120 expressions were significantly correlated with the tumor histological grade (χ^2 = 9.333, P = 009 and χ^= 11.71, P = 0.003), TNM stage (χ^= 8.627, P = 0.035 and χ^= 13.123, P = 0.004), intrahepatic metastasis (χ^= 7.292, P = 0.007 and χ^= 4.657, P = 0.041, respectively) and patients′ survival (χ^= 6.351, P = 0.002 and χ^= 4.023, P = 0.000, respectively). In addition, the expression of P120 was in concordance with that of E-cadherin (χ^ = 13.797, P = 0.000), indicating that the expression of P120 may be dependent on that of E-cadherin. Finally, only P120 expression was found to be an independent prognostic factor in Cox regression model (r = 0.088, P = 0.049). CONCLUSION: Down-regulated expression of E-cadherin and P120 occurs frequently in ICC and contributes to the progression and development of tumor. Both of them may be valuable biologic markers for predicting tumor invasion, metastasis and patients′ survival, but only P120 is an independent prognostic factor for ICC.
To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC).AIMTo investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC).An immunohistochemical study of E-cadherin and P120 catenin was performed on 42 specimens of ICC with a Dako Envision kit.METHODSAn immunohistochemical study of E-cadherin and P120 catenin was performed on 42 specimens of ICC with a Dako Envision kit.The expression of E-cadherin and P120 was reduced in 27 cases (64.3%) and 31 cases (73.8%), respectively. Both E-cadherin and P120 expressions were significantly correlated with the tumor histological grade (chi2 = 9.333, P = 009 and chi2 = 11.71, P = 0.003), TNM stage (chi2= 8.627, P = 0.035 and chi2 = 13.123, P = 0.004), intrahepatic metastasis (chi2= 7.292, P = 0.007 and chi2 = 4.657, P = 0.041, respectively) and patients' survival (chi2= 6.351, P = 0.002 and chi2 = 4.023, P = 0.000, respectively). In addition, the expression of P120 was in concordance with that of E-cadherin (chi2 = 13.797, P = 0.000), indicating that the expression of P120 may be dependent on that of E-cadherin. Finally, only P120 expression was found to be an independent prognostic factor in Cox regression model (r = 0.088, P = 0.049).RESULTSThe expression of E-cadherin and P120 was reduced in 27 cases (64.3%) and 31 cases (73.8%), respectively. Both E-cadherin and P120 expressions were significantly correlated with the tumor histological grade (chi2 = 9.333, P = 009 and chi2 = 11.71, P = 0.003), TNM stage (chi2= 8.627, P = 0.035 and chi2 = 13.123, P = 0.004), intrahepatic metastasis (chi2= 7.292, P = 0.007 and chi2 = 4.657, P = 0.041, respectively) and patients' survival (chi2= 6.351, P = 0.002 and chi2 = 4.023, P = 0.000, respectively). In addition, the expression of P120 was in concordance with that of E-cadherin (chi2 = 13.797, P = 0.000), indicating that the expression of P120 may be dependent on that of E-cadherin. Finally, only P120 expression was found to be an independent prognostic factor in Cox regression model (r = 0.088, P = 0.049).Down-regulated expression of E-cadherin and P120 occurs frequently in ICC and contributes to the progression and development of tumor. Both of them may be valuable biologic markers for predicting tumor invasion, metastasis and patients' survival, but only P120 is an independent prognostic factor for ICC.CONCLUSIONDown-regulated expression of E-cadherin and P120 occurs frequently in ICC and contributes to the progression and development of tumor. Both of them may be valuable biologic markers for predicting tumor invasion, metastasis and patients' survival, but only P120 is an independent prognostic factor for ICC.
To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC). An immunohistochemical study of E-cadherin and P120 catenin was performed on 42 specimens of ICC with a Dako Envision kit. The expression of E-cadherin and P120 was reduced in 27 cases (64.3%) and 31 cases (73.8%), respectively. Both E-cadherin and P120 expressions were significantly correlated with the tumor histological grade (chi2 = 9.333, P = 009 and chi2 = 11.71, P = 0.003), TNM stage (chi2= 8.627, P = 0.035 and chi2 = 13.123, P = 0.004), intrahepatic metastasis (chi2= 7.292, P = 0.007 and chi2 = 4.657, P = 0.041, respectively) and patients' survival (chi2= 6.351, P = 0.002 and chi2 = 4.023, P = 0.000, respectively). In addition, the expression of P120 was in concordance with that of E-cadherin (chi2 = 13.797, P = 0.000), indicating that the expression of P120 may be dependent on that of E-cadherin. Finally, only P120 expression was found to be an independent prognostic factor in Cox regression model (r = 0.088, P = 0.049). Down-regulated expression of E-cadherin and P120 occurs frequently in ICC and contributes to the progression and development of tumor. Both of them may be valuable biologic markers for predicting tumor invasion, metastasis and patients' survival, but only P120 is an independent prognostic factor for ICC.
AIM: To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC). METHODS: An immunohistochemical study of E-cadherin and P120 catenin was performed on 42 specimens of ICC with a Dako Envision kit. RESULTS: The expression of E-cadherin and P120 was reduced in 27 cases (64.3%) and 31 cases (73.8%), respectively. Both E-cadherin and P120 expressions were significantly correlated with the tumor histological grade (χ 2 = 9.333, P = 009 and χ 2 = 11.71, P = 0.003), TNM stage (χ 2 = 8.627, P = 0.035 and χ 2 = 13.123, P = 0.004), intrahepatic metastasis (χ 2 = 7.292, P = 0.007 and χ 2 = 4.657, P = 0.041, respectively) and patients’ survival (χ 2 = 6.351, P = 0.002 and χ 2 = 4.023, P = 0.000, respectively). In addition, the expression of P120 was in concordance with that of E-cadherin (χ 2 = 13.797, P = 0.000), indicating that the expression of P120 may be dependent on that of E-cadherin. Finally, only P120 expression was found to be an independent prognostic factor in Cox regression model ( r = 0.088, P = 0.049). CONCLUSION: Down-regulated expression of E-cadherin and P120 occurs frequently in ICC and contributes to the progression and development of tumor. Both of them may be valuable biologic markers for predicting tumor invasion, metastasis and patients’ survival, but only P120 is an independent prognostic factor for ICC.
Author Bo Zhai He-Xin Yan Shu-Qin Liu Lei Chen Meng-Chao Wu Hong-Yang Wang
AuthorAffiliation Department of Ultrasonic Intervention, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China International Cooperation Laboratory on Signal Transduction, Eastern Hepatobilliary Surgery Institute, Second Military Medical University, Shanghai 200438, China
AuthorAffiliation_xml – name: Department of Ultrasonic Intervention, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China%International Cooperation Laboratory on Signal Transduction, Eastern Hepatobilliary Surgery Institute, Second Military Medical University, Shanghai 200438, China
Author_xml – sequence: 1
  givenname: Bo
  surname: Zhai
  fullname: Zhai, Bo
– sequence: 2
  givenname: He-Xin
  surname: Yan
  fullname: Yan, He-Xin
– sequence: 3
  givenname: Shu-Qin
  surname: Liu
  fullname: Liu, Shu-Qin
– sequence: 4
  givenname: Lei
  surname: Chen
  fullname: Chen, Lei
– sequence: 5
  givenname: Meng-Chao
  surname: Wu
  fullname: Wu, Meng-Chao
– sequence: 6
  givenname: Hong-Yang
  surname: Wang
  fullname: Wang, Hong-Yang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18595142$$D View this record in MEDLINE/PubMed
BookMark eNptkd1rFDEUxYNU7Lb65LsEEV9kaj4mO5OXgpT6AQVF9Dlk7tyZzXYmmSYzrv3vzbJrURECCeR3zz33njNy4oNHQp5zdiGrsn672_YXvMxvqR-RlRBcF6Iu2QlZccaqQktRnZKzlLaMCSmVeEJOea204qVYkduv2C6ALcWfU8SUXPA0dPQLF4yCndE7T_OBTRis710AG8H5MFoKIUYcMtLSnZs3dF7GECkMzjsIk51zRegd0MlGO-KMMT0ljzs7JHx2vM_J9_fX364-FjefP3y6endTQCnVXAipm2qtFLBWdRJlq9RaVwgoealagFYzXTeqFYCorNTc1uvKCts0dQdl18pzcnnQnZZmxBbQz9EOZoputPHeBOvM3z_ebUwffhhRcS1knQVeHQR21nd5bLMNS_TZssm7FozVQjJeZez1sU8Mdwum2YwuAQ55UxiWZNY651DXZQZf_GnowcnvGDLADwDEkFLEzoCb7ZzDyP7cYDgz-6j37Q0vzT7qXPPmn5oH2f_SL4_0Jvj-zuWhGgu3nRswj11VQnMtfwFFJrkP
CitedBy_id crossref_primary_10_1245_s10434_013_3286_x
crossref_primary_10_1002_jhbp_156
crossref_primary_10_1002_jhbp_67
crossref_primary_10_1245_s10434_009_0494_5
crossref_primary_10_1016_j_jhep_2016_09_010
crossref_primary_10_14712_18059694_2017_48
crossref_primary_10_3389_fmolb_2024_1486576
crossref_primary_10_1007_s00432_010_0789_8
crossref_primary_10_1007_s13402_013_0134_8
crossref_primary_10_1002_path_4495
crossref_primary_10_1002_hep4_1114
crossref_primary_10_1002_jcp_25620
crossref_primary_10_1371_journal_pone_0118645
crossref_primary_10_1007_s10585_011_9378_8
crossref_primary_10_1152_ajplung_00144_2017
Cites_doi 10.1007/978-3-662-03432-3
10.1007/s00428-006-0291-5
10.1016/j.bbamcr.2006.07.005
10.1016/S1084-9521(04)00089-8
10.1002/hep.510240627
10.1016/j.jdermsci.2003.12.001
10.1002/hep.510270412
10.1046/j.1365-2559.2002.01392.x
10.1083/jcb.200605022
10.1002/jso.20344
10.1038/modpathol.3880409
10.1136/jcp.2005.026575
10.1046/j.1432-0436.2002.700911.x
10.1006/mcbr.1999.0155
10.1200/JCO.2002.08.159
10.1053/jhep.2001.25087
10.1038/modpathol.3800965
10.3892/ijo.27.4.973
10.1242/jcs.00724
10.1158/0008-5472.CAN-05-1947
10.1046/j.0106-9543.2001.01580.x
10.1046/j.0956-5507.2003.00090.x
10.1038/sj.onc.1207439
10.1053/gast.2003.50142
ClassificationCodes R73
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
2008 The WJG Press and Baishideng. All rights reserved. 2008
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
– notice: 2008 The WJG Press and Baishideng. All rights reserved. 2008
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
5PM
DOI 10.3748/wjg.14.3739
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters
EISSN 2219-2840
EndPage 3744
ExternalDocumentID PMC2719238
wjg200823017
18595142
10_3748_wjg_14_3739
27772919
Genre Journal Article
GroupedDBID ---
123
29R
2B.
2C~
2RA
2WC
36B
53G
5VR
8WL
92F
92I
92L
93N
93R
AAKDD
ACGFO
AENEX
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CDYEO
CHBEP
CIEJG
CQIGP
CS3
CW9
DIK
DU5
E3Z
EBS
EJD
EMB
F5P
FA0
FRP
GX1
HYE
M~E
OK1
P2P
RNS
RPM
SV3
TCJ
TGQ
TR2
W91
WFFXF
XSB
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
4A8
PSX
5PM
ID FETCH-LOGICAL-c435t-239b7655c0d5f3e3d55697ece3145dccd9098b5d2cee5a391a867a2abb8fc4fd3
ISSN 1007-9327
IngestDate Thu Aug 21 14:06:52 EDT 2025
Thu May 29 04:04:10 EDT 2025
Fri Jul 11 08:17:18 EDT 2025
Wed Oct 16 00:47:27 EDT 2024
Tue Jul 01 03:21:41 EDT 2025
Thu Apr 24 23:05:30 EDT 2025
Thu Nov 24 20:26:24 EST 2022
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 23
Keywords Clinicopathologic feature
P120
Survival
Invasion and metastasis
Intrahepatic cholangiocarcinoma
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c435t-239b7655c0d5f3e3d55697ece3145dccd9098b5d2cee5a391a867a2abb8fc4fd3
Notes P120; Intrahepatic cholangiocarcinoma; Clinicopathologic feature; Invasion and metastasis; Survival
Clinicopathologic feature
14-1219/R
Intrahepatic cholangiocarcinoma
P120
R735.7
Survival
Invasion and metastasis
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Fax: +86-21-65566851
Telephone: +86-21-25070846
Correspondence to: Hong-Yang Wang, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobilliary Surgery Institute, Second Military Medical University, Shanghai 200438, China. hywangk@online.sh.cn
Author contributions: Zhai B wrote the paper and organized the figures and patient data, Yan HX and Liu SQ did the immunohistochemical staining assays; Chen L carried out the statistical analysis; Wu MC and Wang HY helped write, organize, and correct the paper; Wang HY supervised the writing and organization process.
OpenAccessLink https://www.wjgnet.com/1007-9327/full/v14/i23/3739.htm
PMID 18595142
PQID 69284884
PQPubID 23479
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2719238
wanfang_journals_wjg200823017
proquest_miscellaneous_69284884
pubmed_primary_18595142
crossref_citationtrail_10_3748_wjg_14_3739
crossref_primary_10_3748_wjg_14_3739
chongqing_backfile_27772919
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-06-21
PublicationDateYYYYMMDD 2008-06-21
PublicationDate_xml – month: 06
  year: 2008
  text: 2008-06-21
  day: 21
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of gastroenterology : WJG
PublicationTitleAlternate World Journal of Gastroenterology
PublicationTitle_FL WORLD JOURNAL OF GASTROENTEROLOGY
PublicationYear 2008
Publisher Department of Ultrasonic Intervention, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China%International Cooperation Laboratory on Signal Transduction, Eastern Hepatobilliary Surgery Institute, Second Military Medical University, Shanghai 200438, China
The WJG Press and Baishideng
Publisher_xml – name: Department of Ultrasonic Intervention, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China%International Cooperation Laboratory on Signal Transduction, Eastern Hepatobilliary Surgery Institute, Second Military Medical University, Shanghai 200438, China
– name: The WJG Press and Baishideng
References ref13
ref12
ref15
ref14
ref11
ref10
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref7
  doi: 10.1007/978-3-662-03432-3
– ident: ref1
– ident: ref10
  doi: 10.1007/s00428-006-0291-5
– ident: ref4
  doi: 10.1016/j.bbamcr.2006.07.005
– ident: ref16
  doi: 10.1016/S1084-9521(04)00089-8
– ident: ref24
  doi: 10.1002/hep.510240627
– ident: ref19
  doi: 10.1016/j.jdermsci.2003.12.001
– ident: ref9
  doi: 10.1002/hep.510270412
– ident: ref29
  doi: 10.1046/j.1365-2559.2002.01392.x
– ident: ref2
  doi: 10.1083/jcb.200605022
– ident: ref27
  doi: 10.1002/jso.20344
– ident: ref14
  doi: 10.1038/modpathol.3880409
– ident: ref11
  doi: 10.1136/jcp.2005.026575
– ident: ref15
  doi: 10.1046/j.1432-0436.2002.700911.x
– ident: ref3
  doi: 10.1006/mcbr.1999.0155
– ident: ref6
– ident: ref21
  doi: 10.1200/JCO.2002.08.159
– ident: ref5
  doi: 10.1053/jhep.2001.25087
– ident: ref20
  doi: 10.1038/modpathol.3800965
– ident: ref26
– ident: ref12
  doi: 10.3892/ijo.27.4.973
– ident: ref17
  doi: 10.1200/JCO.2002.08.159
– ident: ref8
– ident: ref22
  doi: 10.1242/jcs.00724
– ident: ref25
  doi: 10.1158/0008-5472.CAN-05-1947
– ident: ref13
  doi: 10.1046/j.0106-9543.2001.01580.x
– ident: ref28
  doi: 10.1046/j.0956-5507.2003.00090.x
– ident: ref18
  doi: 10.1038/sj.onc.1207439
– ident: ref23
  doi: 10.1053/gast.2003.50142
SSID ssj0023352
Score 1.9646803
Snippet AIM: To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC). METHODS: An...
To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC). An...
To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC).AIMTo investigate...
R73; AIM: To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC).METHODS:...
AIM: To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC). METHODS: An...
SourceID pubmedcentral
wanfang
proquest
pubmed
crossref
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3739
SubjectTerms Adult
Aged
Bile Duct Neoplasms - chemistry
Bile Duct Neoplasms - mortality
Bile Duct Neoplasms - pathology
Bile Ducts, Intrahepatic - chemistry
Bile Ducts, Intrahepatic - pathology
Biomarkers, Tumor - analysis
Cadherins - analysis
Catenins
Cell Adhesion Molecules - analysis
Cholangiocarcinoma - chemistry
Cholangiocarcinoma - mortality
Cholangiocarcinoma - pathology
Down-Regulation
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Staging
P120
Phosphoproteins - analysis
Prognosis
Proportional Hazards Models
Rapid Communication
临床特征
肝肿瘤
Title Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters
URI http://lib.cqvip.com/qk/84123X/200823/27772919.html
https://www.ncbi.nlm.nih.gov/pubmed/18595142
https://www.proquest.com/docview/69284884
https://d.wanfangdata.com.cn/periodical/wjg200823017
https://pubmed.ncbi.nlm.nih.gov/PMC2719238
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgCIkXBOIWxsAPe6LKaC6O40eYNlVTGRe1ouIlchynzbYm0KYa4tdzTuLmQidxkaqoSqwozffl9DvOOZ8JOWSSJ06aBjbEAUhQWBrbIpWQ8wgNAiKOQ79y239_Hoym_tmMzdp2xaq7pIyP1M8b-0r-B1XYB7hil-w_INucFHbAd8AXtoAwbP8K48_ouwqKUf8w5ayV9vvouMMBFjqhbyqWmWP6ms8z-NdaqSwvlnKgcE2OK1lua8_LzbJYmS7JAhcprkPiAI3Bl1gws-6K2LoAp-M5MZfrclWgu-eqtnTCeYYvZ82yXV_NotfviibI1POuI23PsrYoKNtUk7GLjf2p3Xts-kfGOutNUYRYSlX3PZuoivOhIBR5L-z6HXq5XieIerz2N_o9uqNTDkByfTGH-H60HdX30D7_EJ1Ox-NocjKb3CZ3XA6KajuHY9Jw7DKr3oGbi6q7NvHkbzqnRq-NRZHPv4OC6GuWnURkt5727rXMU0C2I1UmD8h9k2PQtzVhHpJbOn9ELg1ZaEsWWqQUyUINWSh8dslCW7JQJAutyEJ3yEJbsjwm09OTyfHINitt2Arkcmm7noh5wJgaJiz1tJcwFgiulfYcnyVKJWIowpglLkgqJj3hyDDg0pXwLKfKTxPvCdnLi1w_I5QPpQDNnAgBR_wkFdjLDYP9IEiGyg8tst_cV1Bq6hL9xyKXY5bnCIu83t7pSBmTelwr5SqCZBUhigAiSFcjhMgih83gb7U3y83DXm0hiyB24gsxmetis44CAeIsDH2LPK0BbE-Dtn-O71qE96BtBqAre_9Ini0qd3aXY9IEv_PAkCAyz-MaL8qtX207_Pkfr2qf3Gsfphdkr1xt9AEo4DJ-WRH6F9bduN4
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduced+expression+of+P120+catenin+in+cholangiocarcinoma+correlated+with+tumor+clinicopathologic+parameters&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Zhai%2C+Bo&rft.au=Yan%2C+He-Xin&rft.au=Liu%2C+Shu-Qin&rft.au=Chen%2C+Lei&rft.date=2008-06-21&rft.issn=1007-9327&rft.volume=14&rft.issue=23&rft.spage=3739&rft_id=info:doi/10.3748%2Fwjg.14.3739&rft.externalDBID=NO_FULL_TEXT
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F84123X%2F84123X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fwjg%2Fwjg.jpg